Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
NGT HealthCare II (NGT) is an early-stage venture capital fund established in Nazareth, Israel, focusing on medical devices and life sciences. Founded to invest in promising technologies, NGT leverages non-dilutive funding from Israel’s Innovation Authority, significantly reducing investment risk. The fund has developed strong relationships with leading universities, hospitals, and research institutions in Israel, which facilitates a continuous flow of investment opportunities.
As an impact fund, NGT aligns its operations with three United Nations Sustainable Development Goals (SDGs), emphasizing social impact alongside financial returns. The organization actively seeks to support Arab entrepreneurs and promote inclusion within Israel's medical startup ecosystem. NGT aims to cultivate an entrepreneurial environment in the Northern periphery of Israel, contributing to economic growth and social mobility.
NGT invests primarily in early-stage medical device and life sciences technologies. The fund's investment strategy emphasizes creating social impact while delivering financial returns to its investors. NGT actively seeks to support Arab entrepreneurs, aiming to foster inclusion and diversity within Israel's medical startup ecosystem.
The fund focuses on pre-seed, seed, and seed-plus stages, with a geographic emphasis on global opportunities, particularly in Asia. NGT's investment thesis highlights the importance of social impact, aiming to contribute to economic growth and social mobility in underserved regions. The fund's commitment to these principles is evident in its outreach and operational strategies.
NGT's portfolio includes several notable companies that have achieved significant exits:
These companies exemplify NGT's focus on high-potential medical technologies and life sciences, showcasing the fund's ability to identify and nurture successful startups in these sectors.
Zohar Gendler: Managing Partner & CEO. Zohar has extensive experience in venture capital and has led multiple successful investments in the medical sector.
Livnat Ben-Zur: Chief Business & Technology Officer. Livnat brings a strong background in technology commercialization and business development.
Nizar Mishael: Managing Partner & CFO. Nizar has a proven track record in financial management and strategic planning within the venture capital space.
Tamar Kedar Harris: Director of Investor Relations. Tamar specializes in building relationships with investors and managing communications.
Qamar Salem: Legal Consultant. Qamar provides legal guidance and support for investment transactions.
Haya Fahoum Darawshi: Administrative Manager. Haya oversees administrative functions and ensures smooth operations.
Lina Totry Ghrayeb: Accounting Assistant. Lina supports the financial operations of the fund.
Startups interested in pitching to NGT should submit their proposals through the website or via email. A comprehensive pitch deck is essential, detailing the business model, market opportunity, and team qualifications. NGT values clear communication and expects a response within a reasonable timeframe after submission.
In recent months, NGT has continued to engage actively with the startup ecosystem, leveraging its relationships with universities and research institutions to identify promising investment opportunities. The fund's focus on social impact and support for Arab entrepreneurs remains a consistent theme in its outreach.
NGT has also been involved in discussions around fostering inclusion within Israel's medical startup ecosystem, highlighting its commitment to economic growth in the Northern periphery of Israel.
What are NGT's investment criteria?
NGT focuses on early-stage medical device and life sciences technologies, emphasizing social impact and financial returns. The fund seeks to invest in companies that align with its mission of supporting Arab entrepreneurs and fostering inclusion.
How can startups apply or pitch to NGT?
Startups can pitch to NGT through their website at ngt-healthcare2.com or by emailing info@ngt-healthcare2.com. A detailed pitch deck should be included, outlining the business model, market opportunity, and team background.
What makes NGT different from other venture capital firms?
NGT distinguishes itself by combining financial returns with a strong commitment to social impact, particularly in supporting Arab entrepreneurs within Israel's medical startup ecosystem.
What is NGT's geographic scope?
NGT has a global investment focus, with particular attention to opportunities in Asia and the Northern periphery of Israel.
What is the typical check size for NGT's investments?
While specific check sizes are not disclosed, NGT invests at the pre-seed, seed, and seed-plus stages, indicating a focus on early-stage funding.
What kind of post-investment involvement does NGT have?
NGT maintains close relationships with its portfolio companies, providing support through its network of universities, hospitals, and research institutions, which can facilitate further growth and development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.